Avidity Partners Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $406K | Buy |
+105,000
| New | +$406K | 0.08% | 53 |
|
|
2023
Q4 | – | Sell |
-1,159,900
| Closed | -$3.02M | – | 73 |
|
|
2023
Q3 | $3.02M | Sell |
1,159,900
-14,200
| -1% | -$36.9K | 0.12% | 78 |
|
|
2023
Q2 | $4.14M | Sell |
1,174,100
-141,100
| -11% | -$498K | 0.14% | 84 |
|
|
2023
Q1 | $5.55M | Sell |
1,315,200
-2,674,800
| -67% | -$11.3M | 0.18% | 71 |
|
|
2022
Q4 | $65.6M | Buy |
3,990,000
+1,306,000
| +49% | +$21.5M | 1.42% | 25 |
|
|
2022
Q3 | $34.3M | Sell |
2,684,000
-297,000
| -10% | -$3.79M | 0.7% | 44 |
|
|
2022
Q2 | $34.9M | Buy |
2,981,000
+116,000
| +4% | +$1.36M | 0.8% | 33 |
|
|
2022
Q1 | $17.4M | Buy |
2,865,000
+100,000
| +4% | +$609K | 0.36% | 55 |
|
|
2021
Q4 | $25.3M | Buy |
2,765,000
+597,100
| +28% | +$5.47M | 0.54% | 51 |
|
|
2021
Q3 | $24.5M | Buy |
+2,167,900
| New | +$24.5M | 0.54% | 49 |
|